Advanced Search

 

Study ID Status Title Patient Level Data
115523 Completed Observer-blind study to evaluate efficacy, safety, and immunogenicity of GSK Biologicals’ Herpes Zoster vaccine GSK1437173A
115524 Completed Immunogenicity and safety study of GSK Biologicals’ meningococcal vaccine GSK 134612 administered to at risk subjects from 1 to less than 18 years
115532 Active, not recruiting COMBI-AD: A phase III randomized double blind study of dabrafenib (GSK2118436) in COMBInation with trametinib (GSK1120212) versus two placebos in the ADjuvant treatment of high-risk BRAF V600 mutation-positive melanoma after surgical resection
115535 Completed A Randomized, Double Blind, Single Dose, Cross-Over Study to Assess the Cardiovascular Effects of GSK2336805 in Healthy Adult Volunteers
115539 Completed Sero-prevalence of pertussis antibodies and disease awareness among healthcare professionals in Spain
115550 Completed A Single Centre, 5-Period, Randomized Study To Evaluate The Relative Bioavailability Of An Immediate Release Tablet Formulation And Prototype Bioenhanced Formulations Of GSK1325756 In Healthy Elderly Subjects During Suppression Of Gastric Acid Secretion Study Listed on ClinicalStudyDataRequest.com
115553 Completed PROACTYVE pilot:Pilot study of Patient’s adherence to TYKERB™/TYVERB™+capecitabine in metastatic breast cancer–observation of patient adherence and evaluation of predictive factors for patient adherence after providing educational programme
115555 Completed Immunogenicity and safety study of GlaxoSmithKline Biological's live attenuated measles mumps rubella varicella vaccine (PriorixTetra™) when co-administered with conjugated Meningococcal C vaccine (Meningitec®, Nuron Biotechs’ Vaccine) in healthy children
115570 Completed A Single Dose First in Human Study of GSK2398852 Co-Administered with GSK2315698 in Patients with Systemic Amyloidosis
115573 Terminated A repeat-dose, open-label, parallel-group study to assess the pharmacokinetics of GSK1278863 and metabolites in normal subjects and subjects with impaired renal function
115575 Completed MEA115575: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study of Mepolizumab Adjunctive Therapy to Reduce Steroid Use in Subjects with Severe Refractory Asthma Study Listed on ClinicalStudyDataRequest.com
115576 Completed An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
115578 Recruiting Post Marketing Surveillance (PMS) of safety and efficacy of Votrient in Korean patients
115579 Completed An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and efficacy of ALTARGO(retapamulin) administered in Korean patients according to the prescribing information
115587 Withdrawn Retigabine Observational Study in Epilepsy (ROSE) Study
115588 Completed MEA115588 A randomised, double-blind, double-dummy, placebo-controlled, parallel-group, multi-centre study of the efficacy and safety of mepolizumab adjunctive therapy in subjects with severe uncontrolled refractory asthma Study Listed on ClinicalStudyDataRequest.com
115596 Completed RES115596: Estimation of Skeletal Muscle Mass with D3 Creatine Pharmacokinetic Study in Healthy Volunteers
115597 Completed Study to determine protective efficacy against otitis media and assess safety of an investigational pneumococcal vaccine 2189242A in healthy infants
115601 Completed A Phase I/II, Open-label Study of Ofatumumab added to Chlorambucil in Previously Untreated Japanese Patients with Chronic Lymphocytic Leukemia
115611 Active, not recruiting ADA gene transfer into hematopoietic stem/progenitor cells for the treatment of ADA-SCID
115616 Active, not recruiting Efficacy of GSK Biologicals’ candidate tuberculosis (TB) vaccine GSK 692342 against TB disease, in adults living in a TB endemic region
115639 Completed A study in adolescent females to explore cytomegalovirus infection
115645 Completed A Randomised, Multi-Centre, Double-Blind, Double-Dummy, Two Way Cross-Over, Twelve Weeks Non-inferiority Study to Evaluate the Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol 250/50 mcg Twice Daily Delivered through a Capsule-Based Inhaler and a Multi-Dose Inhaler in Adults and Adolescents with Asthma Study Listed on ClinicalStudyDataRequest.com
115646 Completed A Randomised Multi-Centre, Double-Blind, Double-Dummy, Two Way Cross-Over, Twelve Weeks Non-inferiority Study to Evaluate The Efficacy, Safety, and Tolerability of Combination Dry Powder of Fluticasone Propionate and Salmeterol 250/50 mcg Twice Daily Delivered Through a Capsule-Based Inhaler and a Multi-Dose Inhaler for the Treatment of Chronic Obstructive Pulmonary Disease (COPD) Study Listed on ClinicalStudyDataRequest.com
115648 Completed Consistency study of GSK Biologicals’ measles-mumps-rubella (MMR) vaccine (209762) (Priorix®) comparing immunogenicity and safety to Merck & Co., Inc.’s MMR vaccine (M M R®II), in healthy children 12 to 15 months of age

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.